Dongwha Pharm Co Ltd banner

Dongwha Pharm Co Ltd
KRX:000020

Watchlist Manager
Dongwha Pharm Co Ltd Logo
Dongwha Pharm Co Ltd
KRX:000020
Watchlist
Price: 6 630 KRW -0.6% Market Closed
Market Cap: ₩185.2B

Dongwha Pharm Co Ltd
Investor Relations

Dong Wha Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals and medicinal chemicals. The company is headquartered in Seoul, Seoul. The Company’s products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. The company also provides medicine raw materials, health food and drinks, as well as cosmetics. The firm distributes its products within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Doh Joon Yoon
Chairman of the Board and Co-Chief Executive Officer
No Bio Available
Chang-Soo Cho
Co-Chief Executive Officer and President
No Bio Available

Contacts

Address
SEOUL
Seoul
6-8F, Fastfive Tower, 24, Namdaemun-ro 9-gil, Jung-gu
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett